Planrock Market Neutral Income ETF (PRMN)
- Previous Close
29.88 - Open
30.02 - Bid 12.00 x 900
- Ask 47.97 x 900
- Day's Range
29.98 - 30.02 - 52 Week Range
29.36 - 30.28 - Volume
100 - Avg. Volume
304 - Net Assets 2.22M
- NAV 29.91
- PE Ratio (TTM) --
- Yield --
- YTD Daily Total Return 1.05%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 1.30%
The fund strategy follows a proprietary, rules-based methodology that selects global high dividend-paying ETFs or stocks from those listed on an exchange and with significant underlying security liquidity, while using offsetting short positions through equity index futures. The strategy allocates to long and short equity index futures, volatility futures, options and options on futures to neutralize equity risk exposure and control volatility similar to the global bond market, while striving to achieve high dividend income and capital appreciation over the long-term.
PlanRock Investment Management, LLC
Fund Family
Large Blend
Fund Category
2.22M
Net Assets
2023-12-18
Inception Date
Performance Overview: PRMN
Trailing returns as of 4/25/2024. Category is Large Blend.
People Also Watch
Holdings: PRMN
Top 6 Holdings (413.48% of Total Assets)
Sector Weightings
Recent News: PRMN
Research Reports: PRMN
Analyst Report: Laboratory Corporation of America Holdings
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
RatingPrice TargetAnalyst Report: Align Technology, Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
RatingPrice TargetALGN: Raising target price to $303.00
ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $303.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetAnalyst Report: 3M Company
3M is a multinational conglomerate that has operated since 1902, when it was known as Minnesota Mining and Manufacturing. The company is well known for its research and development laboratory and it leverages its science and technology across multiple product categories. As of 2020, 3M is organized into four business segments: safety and industrial, transportation and electronics, healthcare, and consumer. Nearly 50% of the company’s revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of net sales. Many of the company’s 60,000-plus products touch and concern a variety of consumers and end markets.
RatingPrice Target